Monsanto (MON) Set to Gain from Bayer's $66B Buyout Offer

By | December 16, 2016

Monsanto Company’s MON shareowners recently voted to approve the company’s acquisition by the German chemical behemoth, Bayer AG BAYRY . Under the terms of the merger deal, Monsanto’s shareowners will secure $ 128 per share in cash at the closing of the deal.  

Restoring Hope on Bayer’s Tie-Up

Since the acceptance of Bayer’s buyout offer (Sep 14, 2016), Monsanto’s stock recorded an average negative return of 2.03%, as against 2.57% of negative return provided by the Zacks categorized Agriculture/Products industry.

Sluggish global economy, lower investments in agricultural inputs, volatile weather patterns and sturdy competition in grain exports have been putting pressure on the companies offering services within the global seeds, traits and agricultural chemical industry.

Prominent players within the market such as Syngenta AG SYT , The Dow Chemical Company DOW , E. I. du Pont de Nemours and Company DD and ChemChina; all are heading toward collaboration.

Bayer’s $ 66-billion all-cash buyout price has turned out to be a signature deal for the Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

Amid the consolidation contest going on within the industry, Monsanto would likely place itself in a more competitive position by joining hands with the German drug and crop chemical maker.

Moving Ahead

Monsanto declared that Bayer’s partnership would unlock the next tranche of opportunities and growth for its business.

Notably, the stock’s projected sales growth (F1/F0) is currently pegged at 2.41% and estimated earnings per share growth (F1/F0) valued at 4.55%.

In sync with the deal, the company intends to reinforce its existing product portfolio and offer innovative solutions to farmers. Major issues such as food scarcity and rapid climate changes are expected to be addressed more promptly with such services.

Both companies look forward to successfully close the transaction by the fall of 2017. The deal is currently subject to several regulatory approvals and customary closing conditions. However, Bayer has pledged to reimburse a higher break-up fee of $ 2 billion to Monsanto, in case there is a deal blockage due to regulatory turmoil.

The Best Place to Start Your Stock Search

Today, you are invited to download the full list of 220 Zacks Rank #1 “”Strong Buy”” stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 “”Strong Sells”” and other private research. See these stocks free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BAYER A G -ADR (BAYRY): Free Stock Analysis Report

DU PONT (EI) DE (DD): Free Stock Analysis Report

DOW CHEMICAL (DOW): Free Stock Analysis Report

SYNGENTA AG-ADR (SYT): Free Stock Analysis Report

MONSANTO CO-NEW (MON): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Articles

Plantations International